PortfoliosLab logoPortfoliosLab logo
Xenous Holdings, Inc (XITO)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

Highlights

EPS (TTM)
-$0.00
EBITDA (TTM)
$62.02K
Year Range
$0.00 - $0.04

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Xenous Holdings, Inc

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Xenous Holdings, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Xenous Holdings, Inc (XITO) has returned -22.81% so far this year and -83.08% over the past 12 months.


Xenous Holdings, Inc

1D
0.00%
1M
25.71%
YTD
-22.81%
6M
-26.67%
1Y
-83.08%
3Y*
-57.35%
5Y*
-35.03%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Nov 9, 2017, XITO's average daily return is +1.54%, while the average monthly return is +12.33%. At this rate, your investment would double in approximately 0.5 years.

Historically, 30% of months were positive and 70% were negative. The best month was Oct 2022 with a return of +940.0%, while the worst month was Jan 2022 at -73.5%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 4 months.

On a daily basis, XITO closed higher 5% of trading days. The best single day was Feb 25, 2026 with a return of +733.3%, while the worst single day was Feb 24, 2026 at -92.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20260.00%-38.60%25.71%-22.81%
20250.00%0.00%0.00%0.00%0.00%0.00%-67.31%0.00%-29.41%0.00%-5.00%0.00%-78.08%
20240.00%0.00%-17.91%50.00%-30.30%0.00%0.00%2.61%0.00%0.00%0.42%9.70%-2.99%
202327.39%5.50%168.72%0.00%-11.82%-20.00%0.00%0.00%41.75%0.00%-29.45%-33.00%70.70%
2022-73.46%0.00%0.00%34.38%0.00%0.00%0.33%-56.95%0.00%940.00%-16.12%-72.31%-62.80%
202114.36%39.76%0.00%-21.32%13.04%136.69%-48.75%-2.44%0.00%-22.50%-32.26%100.95%77.50%

Benchmark Metrics

Xenous Holdings, Inc has an annualized alpha of 4147.24%, beta of 0.66, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since November 10, 2017.

  • This stock participated in 235.13% of S&P 500 Index downside but only 126.41% of its upside — more exposed to losses than it benefited from rallies.
  • Beta of 0.66 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
4,147.24%
Beta
0.66
0.00
Upside Capture
126.41%
Downside Capture
235.13%

Return for Risk

Risk / Return Rank

XITO ranks 51 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


XITO Risk / Return Rank: 5151
Overall Rank
XITO Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
XITO Sortino Ratio Rank: 9999
Sortino Ratio Rank
XITO Omega Ratio Rank: 100100
Omega Ratio Rank
XITO Calmar Ratio Rank: 77
Calmar Ratio Rank
XITO Martin Ratio Rank: 1414
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Xenous Holdings, Inc (XITO) and compare them to a chosen benchmark (S&P 500 Index).


XITOBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.09

0.90

-0.98

Sortino ratio

Return per unit of downside risk

7.21

1.39

+5.82

Omega ratio

Gain probability vs. loss probability

4.37

1.21

+3.16

Calmar ratio

Return relative to maximum drawdown

-0.90

1.40

-2.30

Martin ratio

Return relative to average drawdown

-1.31

6.61

-7.91

Explore XITO risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Xenous Holdings, Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Xenous Holdings, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Xenous Holdings, Inc was 98.66%, occurring on Feb 24, 2026. The portfolio has not yet recovered.

The current Xenous Holdings, Inc drawdown is 98.03%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.66%Jan 4, 20181916Feb 24, 2026
-36.24%Nov 10, 20171Nov 10, 20176Nov 20, 20177
-30%Nov 28, 20171Nov 28, 201724Jan 3, 201825

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Xenous Holdings, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Xenous Holdings, Inc is priced in the market compared to other companies in the Shell Companies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items